Lab online
————.——.—— · ——:——:—— UTC
§ PP-002Thymosin fragment

TB-500

Thymosin Beta-4 Fragment

Actin-sequestering peptide fragment. Lyophilised, sealed at 18 °C. Isolated for its structural simplicity and synthetic accessibility, TB-500 is produced as a lyophilised solid and sealed under inert atmosphere.

Every batch moves through the full Six-Step protocol — solid-phase Fmoc synthesis, TFA cleavage, reverse-phase HPLC purification, and ESI-TOF mass-spec confirmation. The lot shipped carries ≥ 99.11% HPLC-MS purity with residual solvent and endotoxin assays signed by an independent laboratory.

Lyophilised vials are stable at −20 °C in their sealed amber container. In bacteriostatic water, HPLC-verified purity holds for approximately four weeks under refrigeration; single-thaw only.

Sequence
LKKTETQ
Molecular weight
889.04 g/mol
Purity (HPLC-MS)
99.11%
Dose · fill
10 mg
Lot number
A-4420
CoA date
2026-03-17
Storage
−20 °C · thaw once
Shipping
Cold-chain, 1-day overnight
TB-500 vial
REC · 00:00:08
Spec. PP-002
Lot A-4420
Subject
TB-500 · 10 mg · lyophilised
MW
889.04 g/mol

Fig. — Amber borosilicate vial, argon-flushed, 10 mg fill.

Specifications
Lot
A-4420
Dose
10 mg
In stock
138 vials
Dispatch
Within 24h
Storage
−20 °C · thaw once
Price

Ships in 1–2 business days

§ 03Related monographs

Adjacent entries

BPC-157 vial
PP-001Pentadecapeptide

BPC-157

Body Protective Compound
Sequence
GEPPPGKPADDAGLV
MW
1419.53 g/mol
Purity
99.42%
214in stock
BAC Water vial
PP-009Diluent

BAC Water

Bacteriostatic Water
Sequence
TBD
MW
0 g/mol
Purity
99%
500in stock
Wolverine vial
PP-010Recovery blend

Wolverine

BPC-157 / TB-500 Blend
Sequence
TBD
MW
0 g/mol
Purity
99%
120in stock